You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory/ resistant carcinoid disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Steroid Resistant Acute GVHD Trial in Lyon (inolimomab)

Available
  • Steroid Resistant Acute Graft Versus Host Disease
  • inolimomab
  • Lyon, France
    ElsaLys Biotech
Sep 16, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory

Active, not recruiting
Has Results
  • Castration Levels of Testosterone
  • +9 more
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Carcinoid Tumor, Acromegaly Trial in Worldwide (Pasireotide)

Completed
  • Carcinoid Tumor
  • Acromegaly
  • Los Angeles, California
  • +16 more
Dec 17, 2020

Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)

Completed
  • Germ Cell Tumors
  • Measurable Disease
  • Milano, Mi, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)

Terminated
Has Results
  • Chronic Myeloid Leukemia in Chronic Phase
  • Bruxelles, Belgium
  • +9 more
Jul 14, 2021

Graft Vs Host Disease Trial in United States (ALPN-101)

Terminated
  • Graft Vs Host Disease
  • Miami, Florida
  • +3 more
Aug 24, 2020

Metastatic Castration Resistant Prostate Cancer Trial in United States (LAVA-1207)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • LAVA-1207
  • Tampa, Florida
  • +3 more
Nov 18, 2022

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Osteosarcoma Trial in China, Korea, Republic of (Sulfatinib, Etoposide, Isophosphamide)

Not yet recruiting
  • Osteosarcoma
  • Beijing, Beijing, China
  • +4 more
Oct 19, 2022

Movement Disorders Trial in Beijing (MRgFUS treatment)

Not yet recruiting
  • Movement Disorders
  • MRgFUS treatment
  • Beijing, China
    Chinese PLA General Hospital
Nov 17, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Leukemia, Myeloid, Chronic Trial in Germany, United States (LBH589)

Terminated
Has Results
  • Leukemia, Myeloid, Chronic
  • Duarte, California
  • +25 more
Jul 14, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

Recruiting
  • Locally Advanced Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Neoplasm
  • Placebo Administration
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Thyroid Cancer Trial in Peking (Apatinib)

Completed
  • Thyroid Cancer
  • Peking, China
    Peking Union Medical College Hospital
Jan 18, 2022

Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)

Recruiting
  • Prostate Cancer Patients
  • Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
  • Qingdao, Shandong, China
  • +1 more
May 3, 2022

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Acute GVHD in Intestine, Steroid Refractory GVHD Trial in France, Germany, Spain (MaaT013)

Recruiting
  • Acute Graft Versus Host Disease in Intestine
  • Steroid Refractory GVHD
  • Amiens, France
  • +17 more
Jun 20, 2022

Acute GVHD in Intestine, Steroid Refractory GVHD Trial in France (MaaT013)

Available
  • Acute Graft Versus Host Disease in Intestine
  • Steroid Refractory GVHD
  • Amiens, France
  • +19 more
Jun 20, 2022

Ovarian Cancer Trial in France (Pazopanib, Paclitaxel)

Completed
  • Ovarian Cancer
  • Avignon, France
  • +35 more
Feb 23, 2022

Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem

Recruiting
  • Graft-versus-host Disease
  • +2 more
  • Mesenchymal stem cells
  • Edeghem, Antwerpen, Belgium
  • +11 more
Sep 19, 2022

Ovarian Cancer, Relapsed or Refractory, Chiauranib Trial in Shanghai (chiauranib, Placebo, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 7, 2022

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023